Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of the study is to determine the activity of the weekly combination of
docetaxel (Taxotere) and irinotecan in terms of response rate in subjects with advanced,
previously untreated, non-small cell lung cancer. It is also to determine the activity of
this combination in terms of response duration, time to progression, median survival, overall
survival, and percent one-year survival, as well as the side-effect and toxicity profile of
weekly Taxotere and weekly irinotecan.